How AI describes BPL Plasma

Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this

Kedrion Biopharma collects plasma and produces plasma-derived therapies for rare and ultra-rare diseases, including coagulation and neurological disorders, immunodeficiencies, and Rh sensitization. The company operates 68 plasma collection centers in the U.S., 8 in the Czech Republic, and 7 production facilities across 5 countries, distributing 38 products in over 100 countries.

Parse Score

45.5

#43 of 55 in Biotech and Health Service Providers

Strength5

Reach32

Authority27